Lodestar Investment Counsel’s Thermo Fisher Scientific TMO Stock Holding History

Lodestar Investment Counsel’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$22.3M	Sell	76,051 -120	-0.2%	-$33.1K	2.29%	15
2019 Q1	$20.8M	Sell	76,171 -1,170	-2%	-$291K	2.23%	15
2018 Q4	$17.3M	Buy	77,341 +2,574	+3%	+$604K	2.11%	16
2018 Q3	$18.2M	Sell	74,767 -1,464	-2%	-$337K	1.97%	17
2018 Q2	$15.8M	Buy	76,231 +1,250	+2%	+$265K	1.82%	18
2018 Q1	$15.5M	Buy	74,981 +810	+1%	+$170K	1.8%	21
2017 Q4	$14.1M	Buy	74,171 +1,445	+2%	+$277K	1.62%	21
2017 Q3	$13.8M	Buy	72,726 +1,287	+2%	+$233K	1.69%	21
2017 Q2	$12.5M	Buy	71,439 +1,111	+2%	+$187K	1.59%	22
2017 Q1	$10.8M	Buy	70,328 +2,955	+4%	+$452K	1.4%	25
2016 Q4	$9.51M	Buy	67,373 +8,523	+14%	+$1.26M	1.29%	31
2016 Q3	$9.36M	Buy	58,850 +1,740	+3%	+$268K	1.29%	31
2016 Q2	$8.44M	Buy	57,110 +2,180	+4%	+$322K	1.2%	36
2016 Q1	$7.78M	Buy	54,930 +5,712	+12%	+$765K	1.12%	36
2015 Q4	$6.98M	Buy	49,218 +2,147	+5%	+$286K	1.1%	38
2015 Q3	$5.76M	Buy	47,071 +7,215	+18%	+$940K	0.97%	46
2015 Q2	$5.17M	Buy	39,856 +35,956	+922%	+$4.69M	0.81%	51
2015 Q1	$524K	Buy	3,900 +900	+30%	+$116K	0.08%	97
2014 Q4	$376K	Hold	3,000	–	–	0.11%	88
2014 Q3	$365K	Hold	3,000	–	–	0.11%	88
2014 Q2	$354K	Hold	3,000	–	–	0.11%	90
2014 Q1	$361K	Buy	+3,000	New	+$357K	0.11%	91

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lodestar Investment Counsel's TMO Position: Q2 2019 in Review

Lodestar Investment Counsel reduced its Thermo Fisher Scientific (TMO) stake by 0.16% in Q2 2019, selling an estimated $33.1K and leaving 76,051 shares worth $22.3M. The position accounts for 2.29% of the portfolio, ranked #15.

Lodestar Investment Counsel first reported a position in TMO in Q1 2014 and has held it in 22 quarters since. 1,559 funds tracked by Wall St. Rank hold TMO as of Q2 2019.

Lodestar Investment Counsel held 76,051 shares of Thermo Fisher Scientific worth $22.3M as of Q2 2019.
Lodestar Investment Counsel sold 120 Thermo Fisher Scientific shares in Q2 2019, an estimated $33.1K.
Thermo Fisher Scientific made up 2.29% of Lodestar Investment Counsel's portfolio in Q2 2019, its #15 holding.
Lodestar Investment Counsel first reported a position in Thermo Fisher Scientific in Q1 2014 and has held it in 22 quarters since.
1,559 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2019.

Based on Lodestar Investment Counsel's 13F filing for Q2 2019, filed 10 Jul 2019.